Personal genomic price drop: 23andMe

What Is 23andMe Really Selling: The Moral Quandary At The Center Of The Personalized Genomics Revolution
Steven Kotler, forbes.com

This week, 23andme, the per­son­al­ized genomics com­pa­ny found­ed by Anne Woj­ci­c­ki, wife of Google co-founder Sergey Brin, got an influx of invest­ment cash ($50 mil­lion). Accord­ing to their press release, they are using the money to bring …

RT @ForbesTech: What Is 23andMe Really Selling: The Moral Quandary At The Center Of The Personalized Genomics Revolution http://flip.it/H1sqW http://flip.it/tKy8R

Related articles

• Why 23andMe Is About More Than You And Me (portal.lillycoi.com)
• 23andMe Discovers Genetic Associations For Myopia (futurepundit.com)
• 23andMe identifies multiple genetic factors impacting development of nearsightedness (eurekalert.org)
• Multiple Genetic Factors Identified That Impact The Development Of Nearsightedness (medicalnewstoday.com)
• 23andMe Finds Multiple Genetic Factors Impacting Nearsightedness (33rdsquare.com)
• 23andMe and the tension between Big Data and privacy in healthcare (freshnetworks.com)
• 23andMe Requests FDA Clearance for DNA Saliva Testing (labsoftnews.typepad.com)
• 23andMe Test Helps Boston Woman (23andme.com)